Recon: Biden outlines plan to prepare for future pandemics; Lilly buys hearing loss gene therapy firm Akous for $487M
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy